The hits keep coming for a research group at the Institute of Microbial Technology (IMTECH) in Chandigarh, India.
Last week, we reported that PLoS ONE was retracting three papers by the research group because “there are no data available underlying this study and thus…the published results are fabricated.” Now, according to The Hindu, four more papers are being retracted:
Continue reading Authors of three retracted PLOS ONE papers to retract four more, with one researcher resigning
Guangwen Tang, a rice researcher at Tufts University, landed in hot water in 2012 after her team was accused of feeding Chinese children genetically modified Golden Rice without having obtained informed consent from the parents.
Now, she’s suing both Tufts and the American Journal of Clinical Nutrition, which reportedly is retracting a paper, “ß-carotene in Golden Rice is as good as p-carotene in oil at providing vitamin A to children,” based on the federally funded research, claiming that the retraction would constitute defamation. (That retraction hasn’t happened yet.)
This isn’t the first time we’ve heard the retraction = defamation line. Readers might remember Ariel Fernandez, who threatened to sue us for writing about an expression of concern. Maybe a course on the Streisand Effect should be mandatory for PhD students?
Continue reading Rice researcher in ethics scrape threatens journal with lawsuit over coming retraction
The authors of a 2012 paper in the journal Interface have had the journal issue an expression of concern about it after issues with “some of the data and methods” came to light.
Here’s the expression of concern for “What makes an accurate and reliable subject-specific finite element model? A case study of an elephant femur:” Continue reading Authors issue their own expression of concern about elephant femur paper
PLOS ONE has retracted a 2012 article by a group of breast cancer researchers after another scientist — a leading U.S. oncologist — objected that the data came from his lab.
The paper, “GREB1 Functions as a Growth Promoter and Is Modulated by IL6/STAT3 in Breast Cancer,” came from a team composed of researchers at the Morehouse School of Medicine, Xavier University of Louisiana and the University of Miami School of Medicine. It purported to find that: Continue reading PLOS ONE retracts breast cancer genetics paper after claim of misappropriated data
A second Nature paper co-authored by Pankaj Dhonukshe, formerly of Utrecht University and VIB Ghent, has been retracted.
Here’s the notice for “Generation of cell polarity in plants links endocytosis, auxin distribution and cell fate decisions:” Continue reading Second Nature paper by researcher found to have violated academic integrity retracted
Here’s a new category for us: Poetry.
Comparative Studies of South Asia, Africa and the Middle East, a comparative studies journal, has retracted a paper on gender roles in Middle Eastern poetry due to plagiarism.
Nizar Kabbani was a famed Syrian poet who wrote frankly about feminism, love, and sex. He’s well worth a read, if you have the time – here’s an excerpt from one of his more famous poems, I Have No Power: Continue reading Poetry, politics, plagiarism, and erotics add up to a retraction
The editors of PLoS ONE have issued an expression of concern for a 2014 article on a form of nitrogen-fixing bacteria called Bacillus pumilus.
The reason: The company that provided the strain of microbe used in the research won’t let other researchers look at the organism.
The article is titled “Bacillus pumilus Reveals a Remarkably High Resistance to Hydrogen Peroxide Provoked Oxidative Stress,” and it came from a group led by Stefan Handtke, of the University of Greifswald, in Germany.
Here’s the notice: Continue reading PLoS ONE issues expression of concern when company won’t share bacterial strain
Sometimes plagiarism, like an onion, has layers.
That appears to be the case in a paper brought to our attention by sharp-eyed reader Vladimir Baulin, whose work was copied in a 2006 paper that Journal of Biological Physics retracted for plagiarism.
But you can’t keep a good thief down: the plagiarizing authors just popped up in a new journal with a Chinese-language version of their retracted paper, that looks an awful lot like a knock-off. Here’s a note from Baulin: Continue reading Recursive plagiarism? Researchers may have published a duplicate of a study retracted for plagiarism
A publication on a new, tastier dissolving tablet has been retracted for data errors. Here’s the brief notice for “Meloxicam Taste-Masked Oral Disintegrating Tablet with Dissolution Enhanced by Ion Exchange Resins and Cyclodextrin“: Continue reading “Error in data compilation” leaves bitter taste for paper on sweeter-tasting pills
We came across a rather long-toothed retraction in the Journal of the American Statistical Association, which represents a case of doing the right thing (similar to that involving the apparent first-ever English language retraction from 1756, about which we wrote in 2012).
The 1927 notice came in the form of a letter by C. H. Whelden Jr., who was for a time the chief statistician for the American National Red Cross, referencing his 1926 article in the JASA,”The Trend-Seasonal Normal in Time Series:”
Continue reading Dipping into history: An 87-year-old retraction in a statistics journal